待处理
入排:排除
图源:待检查
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer.
Lior Z Braunstein, Melissa P Mitchell, Hanna Bandos, William M Sikov, Atif J Khan, Peter Y Chen, Patricia A Ganz, Reshma Jagsi, Julia R White, Reena S Cecchini, Hyejoo Kang, Shannon L Puhalla, Kelly L Bolton, Eileen P Connolly, Erica M Stringer-Reasor, Kimberly R Gergelis, Thomas B Julian, Eleftherios P Mamounas, Norman Wolmark
Future Oncol 21(16) 2017-2025
摘要
摘要
NCT05705401 (ClinicalTrials.gov).
KM 提取结果
0 个 Figure · 0 个 KM 面板